Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular

The MOU supports exploration of a nuclear test reactor site at the Utah San Rafael Energy Lab to adv

Rafael (NYSE: RFL - Get Free Report) and Oncology Pharma (OTCMKTS:ONPH - Get Free Report) are both s

72% of Drilled Holes Return Uranium Mineralization; 3D Drill Targets Generated Across Historical Uta

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark

Former SOCOM Senior Technical Advisor to CIO/J6 and Executive Communications Chief to Guide Sekur's

Highly accomplished executive with extensive exploration, strategy, corporate development and capita

Rafael Holdings' Phase 3 clinical trial of a drug named Trappsol Cyclo just got over. Results of the

Dutch beer maker Heineken has appointed Rafael Oliveira as its new chair and CEO, it ​said on Tuesda

Amsterdam, 23 June 2026 Heineken N.V. announces nomination of Rafael Oliveira as Chief Executive Off

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.08) per share. This is a 57.89 percent i

NEWARK, N.J., June 11, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its

The company has had a pre-NDA meeting with the FDA and expects to submit an NDA in second half of ca

Topline results are expected to be announced in second half of calendar 2026 The company has had a p

Rafael Holdings, Inc. (NYSE:RFL) today announced that its subsidiary, Cyclo Therapeutics, has entere

License of the MIT patent strengthens Rafael's intellectual property around cyclodextrins as an Acti

Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) and Rafael (NYSE: RFL - Get Free Report) are

Transaction creates global coffee powerhouse  Oliveira will continue as JDE Peet's CEO and joins KDP

Transaction creates global coffee powerhouse Oliveira will continue as JDE Peet's CEO and joins KDP

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.13) per share. This is a 31.58 percent i

NEWARK, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported it

Appointments add decades of defense, security, and international program experience to T3 Defense's

Rafael (NYSE: RFL - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Report)

Will use Oracle Health Clinical AI Agent to reduce administrative burden, enable doctors to spend mo

NEWARK, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its

Raytheon-Rafael joint venture opens new factory, ramps up air defense production EAST CAMDEN, Ark. ,

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 86.03 percent i

Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today provided an update to the subscription rights relat

Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today announced revised subscription rights in connection

Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today announced a rights offering, including key dates an

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 416.67 percent

On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' sharehold

Rafael Holdings (NYSE:RFL) reported quarterly earnings of $0.06 per share. This is a 125 percent inc

Continued strong enrollment of pivotal Phase 3 global study (TransportNPC™) evaluating Trappsol® Cyc